Exercise-Induced Irisin and Its Role in Metabolic and Neurological Adaptations: A Narrative Review
DOI:
https://doi.org/10.12775/QS.2026.54.70376Keywords
irisin, myokine, physical activity, metabolism, neuroprotection, insulin sensitivityAbstract
Background. In the context of the increasing prevalence of metabolic and neurodegenerative disorders, growing attention has been directed toward biological factors mediating the beneficial effects of physical activity. Among them, irisin, a myokine released in response to muscle contraction, has emerged as a potential regulator of metabolic and neurological processes. Its role in inter-tissue communication and adaptation to exercise has become a subject of intensive research.
Aim. The aim of this study was to summarize the current state of knowledge regarding exercise-induced irisin and its role in metabolic and neurological adaptations.
Material and methods. A narrative review was conducted using the PubMed and Web of Science databases. The analysis included systematic reviews as well as experimental and clinical studies published between 2017 and 2026 focusing on the role of irisin in metabolism, nervous system function, and responses to physical activity.
Results. Available evidence indicates that irisin is involved in the regulation of glucose and lipid metabolism, improvement of insulin sensitivity, and induction of browning of white adipose tissue. Additionally, irisin appears to exert neuroprotective effects by influencing brain-derived neurotrophic factors (BDNF), supporting neurogenesis and cognitive function. Physical activity, particularly its intensity, type, and duration, plays a key role in modulating circulating irisin levels. However, the findings across studies remain inconsistent, likely due to methodological differences and variability in study populations.
Conclusions. Irisin may represent an important link between physical activity and its beneficial metabolic and neurological effects. Nevertheless, due to the heterogeneity of existing evidence, further well-designed studies are needed to better understand its mechanisms of action and potential clinical applications.
References
Yano, N., Zhao, Y. T., & Zhao, T. C. (2021). The physiological role of irisin in the regulation of muscle glucose homeostasis. Endocrines, 2(3), 266–283. https://doi.org/10.3390/endocrines2030025
Bibliography
Bao, J.-F., She, Q.-Y., Hu, P.-P., Jia, N., & Li, A. (2022). Irisin, a fascinating field in our times. Trends in Endocrinology and Metabolism, 33(9), 601–613. https://doi.org/10.1016/j.tem.2022.06.003
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., Kajimura, S., Zingaretti, M. C., Vind, B. F., Tu, H., Cinti, S., Højlund, K., Gygi, S. P., & Spiegelman, B. M. (2012). A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481(7382), 463–468. https://doi.org/10.1038/nature10777
Cheng, Y., Ma, J., & Bo, S. (2024). Short- and long-term effects of concurrent aerobic and resistance training on circulating irisin levels in overweight or obese individuals: a systematic review and meta-analysis of randomized controlled trials. PeerJ, 12, e17958. https://doi.org/10.7717/peerj.17958
Chen, Y., Ding, J., Zhao, Y., Ju, S., Mao, H., & Peng, X.-G. (2021). Irisin induces white adipose tissue browning in mice as assessed by magnetic resonance imaging. Experimental Biology and Medicine, 246(14), 1597–1606. https://doi.org/10.1177/15353702211006049
Chen, Z., Zhang, Y., Zhao, F., Yin, C., Yang, C., Wang, X., Wu, Z., Liang, S., Li, D., Lin, X., Tian, Y., Hu, L., Li, Y., & Qian, A. (2020). Recombinant Irisin Prevents the Reduction of Osteoblast Differentiation Induced by Stimulated Microgravity through Increasing β-Catenin Expression. International Journal of Molecular Sciences, 21(4). https://doi.org/10.3390/ijms21041259
Choi, J.-W., Jo, S.-W., Kim, D.-E., Paik, I.-Y., & Balakrishnan, R. (2024). Aerobic exercise attenuates LPS-induced cognitive dysfunction by reducing oxidative stress, glial activation, and neuroinflammation. Redox Biology, 71, 103101. https://doi.org/10.1016/j.redox.2024.103101
Cigrovski Berkovic, M., Cigrovski, V., & Ruzic, L. (2025). Role of irisin in physical activity, sarcopenia-associated type 2 diabetes, and cardiovascular complications. World Journal of Methodology, 15(4), 105462. https://doi.org/10.5662/wjm.v15.i4.105462
Deng, J., Zhang, N., Wang, Y., Yang, C., Wang, Y., Xin, C., Zhao, J., Jin, Z., Cao, F., & Zhang, Z. (2020). FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction. Stem Cell Research & Therapy, 11(1), 228. https://doi.org/10.1186/s13287-020-01746-z
Du, J., Fan, X., Yang, B., Chen, Y., Liu, K.-X., & Zhou, J. (2019). Irisin pretreatment ameliorates intestinal ischemia/reperfusion injury in mice through activation of the Nrf2 pathway. International Immunopharmacology, 73, 225–235. https://doi.org/10.1016/j.intimp.2019.05.011
Islam, M. R., Valaris, S., Young, M. F., Haley, E. B., Luo, R., Bond, S. F., Mazuera, S., Kitchen, R. R., Caldarone, B. J., Bettio, L. E. B., Christie, B. R., Schmider, A. B., Soberman, R. J., Besnard, A., Jedrychowski, M. P., Kim, H., Tu, H., Kim, E., Choi, S. H., … Wrann, C. D. (2021). Exercise hormone irisin is a critical regulator of cognitive function. Nature Metabolism, 3(8), 1058–1070. https://doi.org/10.1038/s42255-021-00438-z
Lee, K., & Kim, M. (2025). Evolutionary Insights into Irisin/FNDC5: Roles in Aging and Disease from Drosophila to Mammals. Biomolecules, 15(2). https://doi.org/10.3390/biom15020261
Lin, X., & Li, H. (2021). Obesity: epidemiology, pathophysiology, and therapeutics. Frontiers in Endocrinology, 12, 706978. https://doi.org/10.3389/fendo.2021.706978
Liu, S., Cui, F., Ning, K., Wang, Z., Fu, P., Wang, D., & Xu, H. (2022). Role of irisin in physiology and pathology. Frontiers in Endocrinology, 13, 962968. https://doi.org/10.3389/fendo.2022.962968
Lourenco, M. V., de Freitas, G. B., Raony, Í., Ferreira, S. T., & De Felice, F. G. (2022). Irisin stimulates protective signaling pathways in rat hippocampal neurons. Frontiers in Cellular Neuroscience, 16, 953991. https://doi.org/10.3389/fncel.2022.953991
Lourenco, M. V., Ribeiro, F. C., Sudo, F. K., Drummond, C., Assunção, N., Vanderborght, B., Tovar-Moll, F., Mattos, P., De Felice, F. G., & Ferreira, S. T. (2020). Cerebrospinal fluid irisin correlates with amyloid-β, BDNF, and cognition in Alzheimer’s disease. Alzheimer’s & Dementia : Diagnosis, Assessment & Disease Monitoring, 12(1), e12034. https://doi.org/10.1002/dad2.12034
Mazur-Bialy, A. I., Pocheć, E., & Zarawski, M. (2017). Anti-Inflammatory Properties of Irisin, Mediator of Physical Activity, Are Connected with TLR4/MyD88 Signaling Pathway Activation. International Journal of Molecular Sciences, 18(4). https://doi.org/10.3390/ijms18040701
Mohammad Rahimi, G. R., Hejazi, K., & Hofmeister, M. (2022). The effect of exercise interventions on Irisin level: a systematic review and meta-analysis of randomized controlled trials. EXCLI Journal, 21, 524–539. https://doi.org/10.17179/excli2022-4703
Muzaffar, S., Tyagi, A., & Pugazhenthi, S. (2025). Therapeutic potential of irisin in neurodegenerative diseases. International Journal of Molecular Sciences, 26(23). https://doi.org/10.3390/ijms262311348
Natalicchio, A., Marrano, N., Biondi, G., Dipaola, L., Spagnuolo, R., Cignarelli, A., Perrini, S., Laviola, L., & Giorgino, F. (2020). Irisin increases the expression of anorexigenic and neurotrophic genes in mouse brain. Diabetes/Metabolism Research and Reviews, 36(3), e3238. https://doi.org/10.1002/dmrr.3238
Pahlavani, H. A. (2023). Exercise therapy to prevent and treat Alzheimer’s disease. Frontiers in Aging Neuroscience, 15, 1243869. https://doi.org/10.3389/fnagi.2023.1243869
Paoletti, I., & Coccurello, R. (2024). Irisin: A multifaceted hormone bridging exercise and disease pathophysiology. International Journal of Molecular Sciences, 25(24). https://doi.org/10.3390/ijms252413480
Pignataro, P., Dicarlo, M., Zerlotin, R., Storlino, G., Oranger, A., Sanesi, L., Lovero, R., Buccoliero, C., Mori, G., Colaianni, G., Colucci, S., & Grano, M. (2022). Antidepressant Effect of Intermittent Long-Term Systemic Administration of Irisin in Mice. International Journal of Molecular Sciences, 23(14). https://doi.org/10.3390/ijms23147596
Rahimi, M., Nazarali, P., & Alizadeh, R. (2021). Pilates and TRX training methods can improve insulin resistance in overweight women by increasing an exercise-hormone, Irisin. Journal of Diabetes and Metabolic Disorders, 20(2), 1455–1460. https://doi.org/10.1007/s40200-021-00887-z
Shi, X., Gu, Q., Fu, C., Ma, J., Li, D., Zheng, J., Chen, S., She, Z., Qi, X., Li, X., Wu, S., & Wang, L. (2024). Relationship of irisin with disease severity and dopamine uptake in Parkinson’s disease patients. NeuroImage. Clinical, 41, 103555. https://doi.org/10.1016/j.nicl.2023.103555
Song, R., Zhao, X., Cao, R., Liang, Y., Zhang, D.-Q., & Wang, R. (2021). Irisin improves insulin resistance by inhibiting autophagy through the PI3K/Akt pathway in H9c2 cells. Gene, 769, 145209. https://doi.org/10.1016/j.gene.2020.145209
Storlino, G., Colaianni, G., Sanesi, L., Lippo, L., Brunetti, G., Errede, M., Colucci, S., Passeri, G., & Grano, M. (2020). Irisin Prevents Disuse-Induced Osteocyte Apoptosis. Journal of Bone and Mineral Research, 35(4), 766–775. https://doi.org/10.1002/jbmr.3944
Ulupinar, S., Ozbay, S., Gencoglu, C., Altinkaynak, K., Sebin, E., & Oymak, B. (2021). Exercise in the cold causes greater irisin release but may not be enough for adropin. The Chinese Journal of Physiology, 64(3), 129–134. https://doi.org/10.4103/cjp.cjp_2_21
Wang, Q., Ma, L., Zhang, Y., Zhang, L., An, Y., Liu, J., & Wang, G. (2021). Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders, 12(4), 1029–1039. https://doi.org/10.1007/s13300-021-01023-z
Waseem, R., Shamsi, A., Mohammad, T., Hassan, M. I., Kazim, S. N., Chaudhary, A. A., Rudayni, H. A., Al-Zharani, M., Ahmad, F., & Islam, A. (2022). Fndc5/irisin: physiology and pathophysiology. Molecules, 27(3). https://doi.org/10.3390/molecules27031118
Wu, Y., Wu, Y., Yu, J., Zhang, Y., Li, Y., Fu, R., Sun, Y., Zhao, K., & Xiao, Q. (2023). Irisin ameliorates D-galactose-induced skeletal muscle fibrosis via the PI3K/Akt pathway. European Journal of Pharmacology, 939, 175476. https://doi.org/10.1016/j.ejphar.2022.175476
Yano, N., Zhao, Y. T., & Zhao, T. C. (2021). The physiological role of irisin in the regulation of muscle glucose homeostasis. Endocrines, 2(3), 266–283. https://doi.org/10.3390/endocrines2030025
Zhang, X., Xu, S., Hu, Y., Liu, Q., Liu, C., Chai, H., Luo, Y., Jin, L., & Li, S. (2023). Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson’s disease. Npj Parkinson’s Disease, 9(1), 13. https://doi.org/10.1038/s41531-023-00453-9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Julia Anna Malec, Lidia Kulig, Zuzanna Winiarska, Weronika Maria Woźniak, Marcin Wieleba, Barbara Izabela Krupska, Magdalena Zapalska, Sara Steć, Eliza Wiercioch, Franciszek Włodarczyk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 51
Number of citations: 0
